NORCROSS, Ga., May 1—Recently released statistics from Healthcare Products Information Services (HPIS) indicate that MediPurpose™, a medical device innovation and medical product distribution company, is one of the top three safety lancet companies in the United States.
HPIS, a service of Global Healthcare Exchange, provides critical market intelligence for the U.S. healthcare market.
According to HPIS data for the first quarter of 2007, the SurgiLance® Safety Lancet—designed, manufactured and sold by MediPurpose—has surged forward to claim the #3 spot in the U.S. safety lancet market.
"We are committed to growth in the safety lancet arena," said MediPurpose founder and CEO Patrick Yi. "The reliability of the SurgiLance Safety Lancets continues to earn the approval of our existing customers and gain favor with healthcare professionals."
Yi said the unique pre-armed capability of the SurgiLance® Safety Lancet is a major reason for continued gains in market share. Not only is the product simple to use, it also minimizes patient pain and protects healthcare professionals from needlestick injury.
Lancets are commonly used in hospitals, physician offices, laboratories, OBGYN practices, oncology departments, emergency medical services, nursing homes and blood banks.
Founded in 1999, MediPurpose is a leading medical device company headquartered in Singapore, with offices in the United States and the United Kingdom.
Known for its innovation of the SurgiLance® Safety Lancet, MediPurpose has leveraged its success in the medical device industry to become a master medical product distributor.
MediPurpose also offers angel funding, medical product development and medical device consulting for medical device inventors and medical product companies seeking entrance or expansion into the medical device markets.
For more information about MediPurpose's medical products, medical distribution channel management services and medical product development services, please visit www.medipurpose.com.